Reckitt vs J.M. Smucker Company (The)
Side-by-side comparison of AI visibility scores, market position, and capabilities
British consumer health company with £14B revenue; Lysol, Mucinex, Nurofen, and Durex brands managing Mead Johnson infant formula litigation while competing with P&G and J&J.
About
Reckitt is a British multinational consumer health and hygiene company producing market-leading brands including Nurofen (ibuprofen), Strepsils, Dettol, Lysol, Durex, Mucinex, Enfamil infant formula, and Woolite — competing across OTC health, hygiene and home, and nutrition categories. Listed on the London Stock Exchange (LSE: RKT) and headquartered in Slough, England, Reckitt generates approximately £14 billion ($17 billion) in annual revenue. The company has undergone significant portfolio reshaping, divesting its Infant Formula & Child Nutrition (IFCN) business in some markets and selling Mead Johnson Nutrition operations.\n\nReckitt's business is organized into two segments: Health (Nurofen, Strepsils, Gaviscon, Mucinex, DayQuil/NyQuil in North America) and Hygiene and Home (Lysol/Dettol disinfectants, Finish dishwasher tablets, Vanish stain remover, Air Wick). The Health segment benefits from strong brand equity in OTC medications that command premium pricing. The Hygiene segment's Lysol brand benefited significantly from COVID-19 disinfectant demand and has sustained elevated brand awareness post-pandemic.\n\nIn 2025, Reckitt faces ongoing challenges from its $2.4 billion acquisition of Mead Johnson (Enfamil) — the company has faced significant litigation related to NEC (necrotizing enterocolitis) lawsuits claiming preterm infant formula contributed to infant deaths, resulting in large court judgments against Reckitt in 2024. The company is managing these legal liabilities while continuing to run its core consumer health and hygiene portfolio. Reckitt competes with Procter & Gamble, Johnson & Johnson, and Haleon for OTC health and hygiene market share. The 2025 strategy focuses on its Power Brands in health and hygiene, cost efficiency, and resolving the Mead Johnson litigation exposure.
Orrville OH consumer foods (NYSE: SJM) at $8.7B FY2025 revenue (+7%); Uncrustables fastest-growing brand, Hostess ($5.6B acquisition 2023) integration challenge, Jif/Folgers/Café Bustelo portfolio competing with Kraft Heinz.
About
The J.M. Smucker Company is an Orrville, Ohio-based consumer packaged goods company — publicly traded on the New York Stock Exchange (NYSE: SJM) as an S&P 500 Consumer Staples component — manufacturing and marketing a portfolio of leading food and beverage brands across coffee, peanut butter, fruit spreads, frozen sandwiches, and sweet baked goods through approximately 8,500 employees, with fiscal year 2025 net sales of $8.7 billion (+7% year-over-year). J.M. Smucker's brand portfolio spans three segments: U.S. Retail Pet Foods (Milk-Bone dog treats, Meow Mix, 9Lives, Kibbles 'n Bits), U.S. Retail Coffee (Folgers, Café Bustelo, Dunkin' retail coffee), and U.S. Retail Consumer Foods (Smucker's jams and jellies, Jif peanut butter, Uncrustables frozen sandwiches, and the Hostess sweet baked snacks portfolio). The Hostess acquisition (November 2023, $5.6 billion) made Smucker the owner of America's most iconic sweet baked goods brands — Twinkies, Donettes, Ding Dongs, Ho Hos, and Hostess CupCakes — while presenting integration challenges as the sweet baked snacks category faces shelf-stable competition from private label and shifting consumer preferences. CEO Mark Smucker (grandson of founder Jerome Monroe Smucker who founded the company in 1897) leads the company's brand portfolio management strategy, with Uncrustables (frozen peanut butter and jelly sandwiches, the fastest-growing Smucker brand) and Café Bustelo (Spanish-language espresso-style coffee, growing with US Hispanic demographics) as the primary growth drivers.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.